The Effect of Activated Charcoal on the Absorption of Fluoxetine, with Special Reference to Delayed Charcoal Administration
- 1 November 1996
- journal article
- clinical trial
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 79 (5) , 270-273
- https://doi.org/10.1111/j.1600-0773.1996.tb00272.x
Abstract
The effect of activated charcoal on fluoxetine (40 mg) absorption, with special reference to delayed charcoal administration, was investigated in a randomized study with four parallel groups of eight Healthy volunteers. The first group ingested fluoxetine on an empty stomach with water only (control). The second group received 25 g of activated charcoal as a suspension immediately after fluoxetine. The third and fourth groups took fluoxetine with water and received 25 g of charcoal 2 or 4 hr after fluoxetine. Timed blood samples were taken and plasma fluoxetine and norfluoxetine concentrations were measured by GC for 96 hr. When charcoal was administered immediately after fluoxetine, the AUC (0-96 hr) of fluoxetine was reduced by more than 96% (P < 0.0005) and the Cmax by more than 98% (P < 0.0005). The reduction in the AUC (0-96 hr) and Cmax of norfluoxetine was similar to that of fluoxetine. When the administration of charcoal was delayed 2 or 4 hr, there was a non-significant mean reduction of 16% and 23% in the AUC (0-96 hr) of fluoxetine. Similarly, the Cmax was not significantly reduced by charcoal given 2 or 4 hr later. Also, the half-life of fluoxetine was not significantly reduced (by 25%) by the late administration of charcoal. We conclude that activated charcoal, ingested immediately after fluoxetine, practically completely prevents the gastrointestinal absorption of fluoxetine. However, regardless of the relatively slow absorption of fluoxetine, delaying charcoal administration 2-4 hr greatly reduces its antidotal efficacy.Keywords
This publication has 19 references indexed in Scilit:
- 1993 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance SystemThe American Journal of Emergency Medicine, 1994
- Comparative Tolerability Profiles of the Newer versus Older AntidepressantsDrug Safety, 1994
- Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdosesThe Lancet, 1993
- The toxicity of drugs used for suicideActa Psychiatrica Scandinavica, 1993
- The Effects of Fluoxetine in the Overdose PatientJournal of Toxicology: Clinical Toxicology, 1990
- Oral Activated Charcoal in the Treatment of IntoxicationsMedical Toxicology, 1988
- FluoxetineDrugs, 1986
- Absorption inhibition and enhancement of elimination of sustained-release theophylline tablets by oral activated charcoalAnnals of Emergency Medicine, 1986
- Do gastric contents modify antidotal efficacy of oral activated charcoal?British Journal of Clinical Pharmacology, 1984
- EFFECT OF ACTIVATED CHARCOAL ON ABSORPTION OF NORTRIPTYLINEThe Lancet, 1977